X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (6) 6
male (5) 5
middle aged (5) 5
aged (4) 4
female (4) 4
myocardial infarction (4) 4
research (4) 4
risk (4) 4
abridged index medicus (3) 3
amino acid sequence (3) 3
angina (3) 3
cardiac & cardiovascular systems (3) 3
cardiovascular diseases (3) 3
cardiovascular diseases - mortality (3) 3
double-blind method (3) 3
mass spectrometry (3) 3
medicine, general & internal (3) 3
membrane proteins (3) 3
molecular sequence data (3) 3
myocardial-infarction (3) 3
acute coronary syndrome - drug therapy (2) 2
basic biological sciences (2) 2
basic electric elements (2) 2
biochemical research methods (2) 2
cardiac catheterization (2) 2
cardiomyopathy, hypertrophic - diagnosis (2) 2
cerebral infarction (2) 2
chromatography (2) 2
chromatography, liquid (2) 2
chromatography, liquid - methods (2) 2
databases, protein (2) 2
devices using stimulated emission (2) 2
dosage and administration (2) 2
drug therapy, combination (2) 2
echocardiography (2) 2
electricity (2) 2
heart attacks (2) 2
heart diseases (2) 2
heart failure - epidemiology (2) 2
hospitalization - statistics & numerical data (2) 2
ischemia (2) 2
kaplan-meier estimate (2) 2
mass spectroscopy (2) 2
myocardial infarction - epidemiology (2) 2
optical elements, systems, or apparatus (2) 2
optics (2) 2
outcomes (2) 2
patients (2) 2
peptides (2) 2
phonocardiography (2) 2
physics (2) 2
prevention (2) 2
proteome - analysis (2) 2
proteomics - methods (2) 2
stroke - epidemiology (2) 2
11 medical and health sciences (1) 1
2-dimensional electrophoresis (1) 1
acetates - adverse effects (1) 1
acetates - therapeutic use (1) 1
acetates; acute coronary syndrome; aged; angina, unstable; atherosclerosis; atorvastatin calcium; double-blind method; early termination of clinical trials; female; heptanoic acids; humans; indoles; male; middle aged; phospholipases a; phospholipases a2, secretory; pyrroles; risk; stroke; survival analysis; treatment outcome; myocardial infarction; medicine (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - complications (1) 1
acute coronary syndromes (1) 1
adamantane (1) 1
adamantane - adverse effects (1) 1
adamantane - analogs & derivatives (1) 1
adamantane - therapeutic use (1) 1
affinity labeling (1) 1
affinity labels - chemistry (1) 1
age (1) 1
aged, 80 and over (1) 1
all-cause (1) 1
amyl nitrite (1) 1
analysis (1) 1
angina pectoris (1) 1
angina, stable - epidemiology (1) 1
angina, unstable (1) 1
angina, unstable - drug therapy (1) 1
angioplasty (1) 1
animals (1) 1
ankle (1) 1
anti-inflammatory drugs (1) 1
aphasia (1) 1
arrhythmias, cardiac - complications (1) 1
arrhythmias, cardiac - diagnosis (1) 1
aspirin (1) 1
aspirin - therapeutic use (1) 1
association (1) 1
atherectomy (1) 1
atherosclerosis (1) 1
atorvastatin calcium (1) 1
atrial contribution (1) 1
automation (1) 1
bacterial (1) 1
bacterial proteins - chemistry (1) 1
behavioral disciplines and activities (1) 1
bleeding (1) 1
blood pressure (1) 1
blood-glucose (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Ray, Kausik K and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Diaz, Rafael and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Loizeau, Virginie and Lopes, Renato D and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and Zeiher, Andreas M and Schwartz, Gregory G and Steg, Philippe Gabriel and Schwartz, Gregory G and Steg, Ph. Gabriel and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Goodman, Shaun G and Harrington, Robert A and Jukema, J. Wouter and Szarek, Michael and White, Harvey D and Zeiher, Andreas M and Tricoci, Pierluigi and Roe, Matthew T and Mahaffey, Kenneth W and Edelberg, Jay M and Hanotin, Corinne and Lecorps, Guillaume and Moryusef, Angèle and Pordy, Robert and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Lopes, Renato D and Gotcheva, Nina N and Prieto, Juan-Carlos and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Takeshi and Kim, Hyo Soo and Kim, Sang-Hyun and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Budaj, Andrzej and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Ristic, Arsen D and Chua, Terrance and Murin, Jan and Fras, Zlatko and Dalby, Anthony J and Tuñón, José and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Ray, Kausik K and Moriarty, Patrick M and Vogel, Robert and ... and ODYSSEY OUTCOMES Committees and Investigators and ODYSSEY OUTCOMES Comm Investigato and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
Molecular & Cellular Proteomics, ISSN 1535-9476, 02/2010, Volume 9, Issue 2, pp. 225 - 241
Journal Article
Radiographics, ISSN 0271-5333, 11/2013, Volume 33, Issue 7, pp. 2065 - 2085
Journal Article
Analytical Chemistry, ISSN 0003-2700, 07/2003, Volume 75, Issue 14, pp. 3596 - 3605
The ability to manipulate and effectively utilize small proteomic samples is important for analyses using liquid chromatography (LC) in combination with mass... 
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 06/2004, Volume 3, Issue 3, pp. 434 - 444
Pseudomonas aeruginosa is one of the most significant opportunistic bacterial pathogens in humans causing infections and premature death in patients with... 
LC-MS/MS | Proteome | Low abundance | Affinity labeling | Membrane proteins | Membranes - metabolism | Amino Acid Sequence | Multiprotein Complexes - metabolism | Affinity Labels - chemistry | Pseudomonas aeruginosa - metabolism | Databases, Protein | Mass Spectrometry | Chromatography, Liquid | Molecular Sequence Data
Journal Article
Analytical Chemistry, ISSN 0003-2700, 07/2003, Volume 75, Issue 14, p. 3264
  A starlike water-soluble fullerene derivative, hexa(sulfonbutyl)fullerene (C60[(CH2)4SO3-16; HSBF), consisting of a C60 cage covalently bonded with six... 
Chemistry | Analysis | Fluid
Journal Article
Analytical chemistry, ISSN 0003-2700, 07/2003, Volume 75, Issue 14, pp. 3264 - 3273
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 06/2004, Volume 3, Issue 3, pp. 434 - 444
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article